BARONCIANI, LUCIANO
BARONCIANI, LUCIANO
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method
2018 F. Stufano, L. Baronciani, D. Mane-Padros, G. Cozzi, S. Faraudo, F. Peyvandi
A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications
2004 L. Hilbert, A. Federici, L. Baronciani, S. Dallagiovanna, C. Mazurier
A synonymous (c.3390C>T) or a splice-site (c.3380-2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE)
2013 M.T. Pagliari, L. Baronciani, I. Garcìa Oya, M. Solimando, S. La Marca, G. Cozzi, F. Stufano, M.T. Canciani, F. Peyvandi
A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen
2013 F. Stufano, A.S. Lawrie, S. La Marca, P.E.C. Berbenni, L. Baronciani, F. Peyvandi
A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome
2014 F. Franchi, E. Biguzzi, F. Stufano, S.M. Siboni, L. Baronciani, F. Peyvandi
Alterata morfologia piastrinica nei pazienti con malattia di von Willebrand tipo 2B e 3 : i dati della microscopia elettronica
2007 M. Punzo, S. La Marca, L. Baronciani, A.B. Federici, A. Nurden, P. Nurden
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees
2004 T.J. Kunicki, A.B. Federici, D.R. Salomon, J.A. Koziol, S.R. Head, T.S. Mondala, J.D. Chismar, L. Baronciani, M.T. Canciani, I.R. Peake
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees
2006 T.J. Kunicki, L. Baronciani, M.T. Canciani, F. Gianniello, S.R. Head, T.S. Mondala, D.R. Salomon, A.B. Federici
An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study
2018 A. Szederjesi, L. Baronciani, U. Budde, G. Castaman, A.S. Lawrie, Y. Liu, R. Montgomery, F. Payvandi, R. Schneppenheim, A. Várkonyi, J. Patzke, I. Bodó
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease
2007 L. Baronciani, A.B. Federici, G. Cozzi, M.T. Canciani, P.M. Mannucci
Bleeding symptoms in patients diagnosed as type 3 Von Willebrand Disease: results from 3WINTERS-IPS, an international and collaborative cross-sectional study
2020 A. Tosetto, Z. Badiee, M. Baghaipour, L. Baronciani, J. Battle, E. Berntorp, I. Bodó, U. Budde, G. Castaman, J.C.J. Eikenboom, P. Eshghi, C. Ettorre, A. Goodeve, J. Goudemand, H. Charles Richard Morris, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F. Lopez Fernandez, P.M. Mannucci, M.G. Mazzucconi, M. Morfini, J. Oldenburg, I. Peake, R. Parra Lòpez, F. Peyvandi, R. Schneppenheim, A. Tiede, G. Toogeh, M. Trossaert, O. Zekavat, E.M.K. Zetterberg, A.B. Federici
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers
2020 A. Szederjesi, L. Baronciani, U. Budde, G. Castaman, P. Colpani, A.S. Lawrie, Y. Liu, R. Montgomery, F. Peyvandi, R. Schneppenheim, J. Patzke, I. Bodó
Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation
2018 M.T. Pagliari, L. Baronciani, F. Stufano, P. Colpani, S.M. Siboni, F. Payvandi
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
2020 F. Stufano, L. Baronciani, P. Bucciarelli, M. Boscarino, P. Colpani, M.T. Pagliari, F. Peyvandi
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
2019 F. Stufano, M. Boscarino, P. Bucciarelli, L. Baronciani, A. Maino, G. Cozzi, F. Peyvandi
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
2021 L. Baronciani, I. Peake, R. Schneppenheim, A. Goodeve, M. Ahmadinejad, Z. Badiee, M.-. Baghaipour, O. Benitez, I. Bodo, U. Budde, A. Cairo, G. Castaman, P. Eshghi, J. Goudemand, W. Hassenpflug, H. Hoorfar, M. Karimi, B. Keikhaei, R. Lassila, F.W.G. Leebeek, M.F.L. Fernandez, P.M. Mannucci, R. Marino, N. Niksic, F. Oyen, C. Santoro, A. Tiede, G. Toogeh, A. Tosetto, M. Trossaert, E.M.K. Zetterberg, J. Eikenboom, A.B. Federici, F. Peyvandi
How we make an accurate diagnosis of von Willebrand disease
2019 L. Baronciani, F. Peyvandi
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease : REPLY from original authors Biguzzi et al
2021 E. Biguzzi, S.M. Siboni, S. le Cessie, L. Baronciani, F.R. Rosendaal, A. van Hylckama Vlieg, F. Peyvandi
Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease
2000 L. Baronciani, G. Cozzi, M.T. Canciani, F. Peyvandi, A. Srivastava, A.B. Federici
Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients
2003 L. Baronciani, G. Cozzi, M.T. Canciani, F. Peyvandi, A. Srivastava, A.B. Federici, P.M. Mannucci